Granules India's Green Plant Ambitions

The transcript discusses the pharmaceutical industry's efforts to become more sustainable, highlighting the significant carbon emissions it generates. It introduces the concept of green paracetamol and partnerships with companies like GreenCo to produce carbon-free products. The discussion covers market expansion in the US and Europe, addressing challenges like price erosion. The importance of regulatory compliance and sustainability is emphasized, along with the financial impacts of changing market conditions. The company aims to lead in green pharmaceuticals while maintaining compliance and adapting to financial challenges.

In what ways is the market for green paracetamol expected to grow, particularly in the US?

How does Granules plan to address the erosion of prices for generic drugs in the US market?

What measures does Granules take to maintain compliance and address reputational damage in the pharmaceutical industry?